The global DNA microarray market was valued at USD 5.14 Billion in 2024, driven by the rising burden of chronic diseases and the increased applications of DNA microarray technology in clinical diagnostics across the globe. The market is further estimated to grow in the forecast period of 2025-2034 at a CAGR of 10.60% to reach about USD 14.08 Billion by 2034.
Base Year
Historical Period
Forecast Period
Increased applications of DNA microarray technology in clinical diagnostics for the detection and diagnosis of various is expected to fuel market demand.
The market value is influenced by the growing demand for personalized medicine, increased adoption of genetic testing, and rising funding for genomics research.
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is poised to significantly influence the market dynamics.
Compound Annual Growth Rate
10.6%
Value in USD Billion
2025-2034
DNA Microarray Market Outlook
*this image is indicative*
A DNA microarray comprises of an assortment of microscopic DNA spots that are connected to a solid surface. Every individual DNA spot comprises several thousands of copies of a particular sequence of DNA, called probes. It is a tool that is utilized to verify whether the DNA sample provided by a particular individual includes a gene mutation such as BRCA1 or BRCA2. The microarray chip consists of a small glass plate that is wrapped in plastic.
The global DNA microarray market is likely to register robust growth due to the rising investment in research and development across the healthcare industry and rising per-capita healthcare expenditure. The increased adoption of genetic testing along with rapid growth in the healthcare infrastructure is further expected to propel the market growth worldwide. Other factors that influence the market include increased application of DNA microarrays in clinical diagnostics, growing demand for personalized medicine, collaborative research initiatives, and integration of bioinformatics and big data analytics with DNA microarray technology.
Increasing Prevalence of Chronic Diseases to Affect the Market Landscape Significantly
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is impacting the market dynamics as microarray technology is widely used to understand and diagnose these diseases. The World Health Organization (WHO) states that 1 out of 5 people is likely to develop cancer in their lifetime. Additionally, it is estimated that more than 35 million new cancer cases will occur in 2050. DNA microarray platforms significantly contribute to advancement in cancer research and play a major role in gene expression analysis and biomarker discovery. Thus, the growing cancer burden propelled by both population aging and growth is projected to boost the market growth.
Growth in Strategic Partnerships to Meet Rising DNA Microarray Market Demand
In July 2023, Spectrum Solutions, a provider of medical and nonmedical contract manufacturing solutions, acquired United States-based biotech firm Microarrays, Inc. which specializes in developing microarray-based assays, as well as a molecular diagnostic laboratory Alimetrix, Inc. Spectrum aims to expand its custom assay and microarray-based products by acquiring Microarrays, Inc. assets and plans to leverage its contract manufacturing and biospecimen collection capabilities to offer a comprehensive suite of services and advance patient care. The rise in such strategic partnerships is anticipated to stimulate innovation and growth in the market.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
The EMR’s report titled “DNA Microarray Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on DNA Microarray Type is Anticipated to Witness Substantial Growth
Based on type, the market is segmented into complementary DNA microarrays, and oligonucleotide DNA microarrays, among others. The oligonucleotide DNA microarray segment is expected to grow over the coming years due to its ability to identify multiple and novel pathogens within a single test. This DNA microarray type leverages innovative technology that potentially permits swift and cost-effective screens for all possible mutations along with sequence variations in genomic DNA and is expected to witness a significant market demand.
Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to hold a significant market share during the forecast period. This is on account of the presence of key players like Illumina, Inc., and Thermo Fisher Scientific Inc., in the region along with increasing investments in technological advancements in genomics. Surging investments by key players in research and development along with the high prevalence of age-related chronic diseases, are anticipated to fuel the market.
Meanwhile, the Asia Pacific region is anticipated to witness substantial growth in the market. Growing awareness regarding genetic testing and growing funding from the government in the healthcare industry across the region are driving market demand. The Asia Pacific region is providing the largest base for clinical trials and drug discovery along with a growing patient population which is further expected to propel the market growth.
The key features of the market report comprise strategic initiatives by the leading key players including patent analysis, fundings and investment analysis, and strategic initiatives by the leading market players. The major companies in the market are as follows:
Headquartered in California, this American biotechnology company is a leading provider of DNA microarray and sequencing technologies. It has a robust portfolio including Bead-Based Microarray Technology that utilizes silica microbeads.
Thermo Fisher Scientific Inc. offers a range of DNA microarray platforms for use in research and clinical diagnostics and contributes significantly to the DNA microarray market growth. This American-headquartered company actively invests in research and development activities to develop and commercialize advanced products.
California-based Agilent Technologies, Inc. is a global leader in laboratory technologies and provides a reliable set of microarray tools for research purposes. The company's microarray platform can be used for postnatal, prenatal, and tumor sample analysis applications.
This life sciences technology company has a prominent presence in the market. Arrayit Corporation is strengthening its market position by investing in the development of novel microarray technologies and forming strategic collaborations with research institutes.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Savyon Diagnostics, SCIENION GmbH, QIAGEN, and PerkinElmer, Inc., among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
